Close Menu

NEW YORK – The US Food and Drug Administration has been updating its guidance for COVID-19 diagnostic tests in a piecemeal fashion as the outbreak expands. On Wednesday, the agency held a webinar to flesh out its evolving policies, providing key insights on regulatory paths for molecular and serological diagnostic testing in commercial and state labs, and for commercial test products and devices.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.